Zobrazeno 1 - 10
of 120
pro vyhledávání: '"José R González-Juanatey"'
Autor:
Sonia Eiras, Rafael de la Espriella, Xiaoran Fu, Diego Iglesias-Álvarez, Rumeysa Basdas, J. R. Núñez-Caamaño, J. M. Martínez-Cereijo, L. Reija, A. L. Fernández, David Sánchez-López, Gema Miñana, Julio Núñez, José R. González-Juanatey
Publikováno v:
Journal of Translational Medicine, Vol 22, Iss 1, Pp 1-14 (2024)
Abstract Background Carbohydrate antigen 125 (CA125) is a proteolytic fragment of MUC-16 that is increased in heart failure (HF) and associated with inflammation, fluid overload, and worse adverse events. Our main objective was to study the expressio
Externí odkaz:
https://doaj.org/article/c278342d89134faf8041b2e7d68bbf98
Autor:
David García-Vega, David Sánchez-López, Gemma Rodríguez-Carnero, Rocío Villar-Taibo, Juan E. Viñuela, Adán Lestegás-Soto, Ana Seoane-Blanco, María Moure-González, Susana B. Bravo, Ángel L. Fernández, José R. González-Juanatey, Sonia Eiras
Publikováno v:
Cardiovascular Diabetology, Vol 23, Iss 1, Pp 1-18 (2024)
Abstract Background Obesity has increased in recent years with consequences on diabetes and other comorbidities. Thus, 1 out of 3 diabetic patients suffers cardiovascular disease (CVD). The network among glucose, immune system, endothelium and epicar
Externí odkaz:
https://doaj.org/article/506bde9bdf8c4d58a30be0ea5ffb9f9c
Autor:
Sergio Raposeiras-Roubín, Bruno K Rodiño-Janeiro, Beatriz Paradela-Dobarro, Lilian Grigorian-Shamagian, José M García-Acuña, Pablo Aguiar-Souto, Michel Jacquet-Hervet, María V Reino-Maceiras, José R González-Juanatey, Ezequiel Álvarez
Publikováno v:
PLoS ONE, Vol 8, Iss 9, p e74302 (2013)
ObjectiveAdvanced glycation end products (AGEs) have pathophysiological implications in cardiovascular diseases. The aim of our study was to evaluate the prognostic value of fluorescent AGEs and its soluble receptor (sRAGE) in the context of acute co
Externí odkaz:
https://doaj.org/article/e9d1cb361344473b8e3e8cf84712cd36
Autor:
José R. González-Juanatey, Jose Luis Górriz, Alberto Ortiz, Alfonso Valle, Maria Jose Soler, Lorenzo Facila
Publikováno v:
Annals of Medicine, Vol 55, Iss 1, Pp 502-513 (2023)
AbstractPersons with diabetes and chronic kidney disease (CKD) have a high residual risk of developing cardiovascular (CV) complications despite treatment with renin-angiotensin system blockers and sodium-glucose cotransporter type 2 inhibitors. Over
Externí odkaz:
https://doaj.org/article/d82a89a5da80471fbf7451b2be3b01ef
Autor:
Pilar Mazón‐Ramos, Belén Álvarez‐Álvarez, Cristina Ameixeiras‐Cundins, Manuel Portela‐Romero, David Garcia‐Vega, Pedro Rigueiro‐Veloso, Daniel Rey‐Aldana, Ricardo Lage‐Fernández, Sergio Cinza‐Sanjurjo, José R. González‐Juanatey
Publikováno v:
ESC Heart Failure, Vol 9, Iss 6, Pp 4150-4159 (2022)
Abstract Aims e‐consults are asynchronous, clinician‐to‐clinician exchanges that answer focused, non‐urgent, patient‐specific questions using the electronic medical record. We instituted an e‐consultation programme (2013–2019) for all g
Externí odkaz:
https://doaj.org/article/a7127b6ef1d94bdbab5ca8b01cfb40ab
Autor:
Belén Alvarez‐Alvarez, Javier García‐Seara, Jose L. Martínez‐Sande, Moisés Rodríguez‐Mañero, Xesús A. Fernández López, Laila González‐Melchor, Diego Iglesias‐Alvarez, Francisco Gude, Carla Díaz‐Louzao, José R. González‐Juanatey
Publikováno v:
Journal of Arrhythmia, Vol 37, Iss 3, Pp 653-659 (2021)
Abstract Introduction The benefit of cardiac resynchronization therapy (CRT) in heart failure (HF) patients with reduced left ventricular ejection fraction (LVEF) have been observed in the first year. However, there are few data on long‐term follow
Externí odkaz:
https://doaj.org/article/7d93d14448d84df6ab8c0da63cb53ac0
Autor:
Estíbaliz Díaz-Balboa, Violeta González-Salvado, Beatriz Rodríguez-Romero, Amparo Martínez-Monzonís, Milagros Pedreira-Pérez, Patricia Palacios-Ozores, Rafael López-López, Carlos Peña-Gil, José R. González-Juanatey
Publikováno v:
BMC Cardiovascular Disorders, Vol 21, Iss 1, Pp 1-12 (2021)
Abstract Background Anthracyclines and monoclonal antibodies against human epidermal growth factor receptor-2 (HER2) are frequently used to treat breast cancer but they are associated with risk of developing cardiotoxicity. Implementation of cardiopr
Externí odkaz:
https://doaj.org/article/c2e13b96cba242a4a63e7c7908963062
Autor:
Pedro Caravaca Perez, José R. González-Juanatey, Jorge Nuche, Lucia Matute-Blanco, Isabel Serrano, Manuel Martínez Selles, Rafael Vázquez García, Luis Martínez Dolz, Manuel Gómez-Bueno, Domingo Pascual Figal, María G. Crespo-Leiro, Álvaro García-Osuna, Jordi Ordoñez-Llanos, Juan Cinca Cuscullola, José M. Guerra, Juan F. Delgado
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 9 (2022)
IntroductionGalectin-3 (Gal-3) is an inflammatory marker associated with the development and progression of heart failure (HF). A close relationship between Gal-3 levels and renal function has been observed, but data on their interaction in patients
Externí odkaz:
https://doaj.org/article/bf3c9abcea524ef585f41ed8bcd750df
Autor:
José R. González-Juanatey
Publikováno v:
REC: Interventional Cardiology, Vol 3, Iss 1, Pp 59-61 (2021)
PREGUNTA: ¿Cuán frecuente es el paciente con agina refractaria y no revascularizable en la actualidad? RESPUESTA: La prevalencia de esta compleja condición se ha incrementado como resultado del mejor pronóstico de los pacientes con cardiopatía i
Externí odkaz:
https://doaj.org/article/b73e4f9f4587402ea50eb5677114e908
Autor:
José R. González-Juanatey
Publikováno v:
REC: Interventional Cardiology (English Ed.), Vol 3, Iss 1, Pp 59-61 (2021)
QUESTION: How often do you see nonrevascularizable patients with refractory angina today? ANSWER: The prevalence of this complex entity has gone up thanks to the better prognosis of patients with ischemic heart disease due to changes of lifestyle, dr
Externí odkaz:
https://doaj.org/article/a45dde4d0cb740bdbcf0d9c7105ffb2c